Luc Dochez

Luc Dochez General Information

Biography

Dr. Luc Dochez is a Co-Founder and serves as Managing Director and Board Member at Vico Therapeutics. He serves as Board Member at Vaderis Therapeutics. He serves as Managing Partner, at Droia Genetic Disease. He serves as Board Member at Highlight Therapeutics, Mahzi Therapeutics and QurAlis. He co-founded harvaris. He also serves as Board Member at Volastra Therapeutics. He is a Co-Founder and serves as Chairman at Montis Biosciences. He was a Board Member and served as Chief Executive Officer of Tusk Therapeutics. He served as Board Member at Summation Bio. He joined Tusk from Prosensa Holding N.V. where he served as Chief Business Officer and Senior Vice President of Business Development for a period of seven years until its acquisition by BioMarin Pharmaceutical Inc. Earlier in his career, he served as Vice President of Business Development at TiGenix, Director of Business Development at Methexis Genomics, and a consultant at Arthur D. Little. He holds a Pharm.D. degree and a postgraduate degree in business economics from the University of Leuven (Belgium) and an MBA from Vlerick Management School (Belgium). He also serves on the Board of Directors of Erytech SA. He also serves as Managing Partner, Genetic Disease at Droia Oncology Ventures. He serves as Board Member at Muna Therapeutics.